Sort
82,697 grants matching “vaccine development”
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,
$2,229,415Ted Ross · University Of Georgia · N01 · FY2022 · AI
Units for HIV/AIDS Clinical Trials Networks
$2,228,690Michael C Keefer · University Of Rochester · U01 · FY2011 · AI
Artificial Ecology Sink as prophylaxis against viral infection
$2,227,500Zhilei Chen · Texas A&M University Health Science Ctr · DP2 · FY2017 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,226,563Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2021 · AI
Impacts of Landscape Structure, Host Demography, and Management Interventions on Disease Dynamics
$2,226,457Sue Vandewoude · Colorado State University · · FY2014 · BIO
Flavivirus Infections: Pathogenesis and Prevention
$2,225,868Alan L Rothman · Univ Of Massachusetts Med Sch Worcester · P01 · FY2008 · AI
HIV/SIV Data Base and Analysis Unit
$2,225,571National Institute Of Allergy And Infectious Diseases · Y01 · FY2016 · AI
A Gene therapeutic approach to stable suppression of HIV-1 replication
$2,225,513Michael R. Farzan · Harvard Medical School · P01 · FY2012 · AI
Health Promotion and Disease Prevention Research Center
$2,224,000Michelle C Kegler · Emory University · U48 · FY2023 · DP
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,223,977A. Darise Farris · Oklahoma Medical Research Foundation · U19 · FY2022 · AI
CARIBBEAN PRIMATE RESEARCH CENTER
$2,222,603Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2012 · OD
Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses
$2,222,178Erica Ollmann Saphire · La Jolla Institute For Immunology · U19 · FY2021 · AI
RESPIRATORY PATHOGENS RESEARCH CENTERS (RPRC)
$2,222,145David Topham · University Of Rochester · N01 · FY2017 · AI
Innovations in Functional B Cell Epitope Discovery for Lyme Disease
$2,221,944Nicholas Mantis · Nysdoh/Health Research, Inc. · N01 · FY2025 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,221,316A. Darise Farris · Oklahoma Medical Research Foundation · U19 · FY2023 · AI
Multicenter AIDS Cohort Study
$2,221,266Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2010 · AI
CARIBBEAN PRIMATE RESEARCH CENTER
$2,220,984Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · P40 · FY2011 · RR
TUBERCULOSIS PREVENTION IN CHILDREN TWO TO LESS THAN 13 YEARS OF AGE WITH AND WITHOUT HIV
$2,220,803Barbara Driver · Westat, Inc. · N01 · FY2023 · HD
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit
$2,220,216Magdalena Elzbieta Sobieszczyk · Columbia University Health Sciences · UM1 · FY2018 · AI
Development/production of H5 influenza DNA plasmid vaccine
$2,219,937Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Adjuvant Development Program
$2,219,451Rhea N Coler · Access To Advanced Health Institute · N01 · FY2009 · AI
A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum.
$2,219,208Justin D. Radolf · University Of Connecticut Sch Of Med/Dnt · U19 · FY2020 · AI
Institute for Clinical and Translational Research
$2,219,191Daniel Ernest Ford · Johns Hopkins University · KL2 · FY2014 · TR
Institute for Clinical and Translational Research
$2,219,191Daniel Ernest Ford · Johns Hopkins University · KL2 · FY2016 · TR
Institute for Clinical and Translational Research
$2,219,191Daniel Ernest Ford · Johns Hopkins University · KL2 · FY2015 · TR